HK1176678A1 - Biochemical serum marker - Google Patents

Biochemical serum marker

Info

Publication number
HK1176678A1
HK1176678A1 HK13103973.0A HK13103973A HK1176678A1 HK 1176678 A1 HK1176678 A1 HK 1176678A1 HK 13103973 A HK13103973 A HK 13103973A HK 1176678 A1 HK1176678 A1 HK 1176678A1
Authority
HK
Hong Kong
Prior art keywords
serum marker
biochemical serum
biochemical
marker
serum
Prior art date
Application number
HK13103973.0A
Other languages
English (en)
Chinese (zh)
Inventor
瑪麗亞．卡特裡納．圖爾科
Original Assignee
比奧尤尼沃薩有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 比奧尤尼沃薩有限責任公司 filed Critical 比奧尤尼沃薩有限責任公司
Publication of HK1176678A1 publication Critical patent/HK1176678A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK13103973.0A 2009-12-04 2013-04-01 Biochemical serum marker HK1176678A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2009A002154A IT1397083B1 (it) 2009-12-04 2009-12-04 Marcatore biochimico serico
PCT/EP2010/068836 WO2011067377A1 (en) 2009-12-04 2010-12-03 Biochemical serum marker

Publications (1)

Publication Number Publication Date
HK1176678A1 true HK1176678A1 (en) 2013-08-02

Family

ID=42244209

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13103973.0A HK1176678A1 (en) 2009-12-04 2013-04-01 Biochemical serum marker

Country Status (14)

Country Link
US (1) US8673585B2 (ja)
EP (1) EP2507635B1 (ja)
JP (1) JP5677450B2 (ja)
KR (1) KR101851392B1 (ja)
CN (1) CN102725638B (ja)
AU (1) AU2010326600B2 (ja)
BR (1) BR112012013418B1 (ja)
CA (1) CA2782544C (ja)
DK (1) DK2507635T3 (ja)
ES (1) ES2530734T3 (ja)
HK (1) HK1176678A1 (ja)
IT (1) IT1397083B1 (ja)
PT (1) PT2507635E (ja)
WO (1) WO2011067377A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397083B1 (it) 2009-12-04 2012-12-28 Biouniversa Srl Marcatore biochimico serico
KR101436684B1 (ko) 2012-03-09 2014-09-01 가톨릭대학교 산학협력단 저산소성 허혈 예방 또는 치료용 조성물
ITMI20130403A1 (it) * 2013-03-18 2014-09-19 Biouniversa Srl Anticorpi anti-bag3 per uso terapeutico
EP2676966A1 (en) 2012-06-19 2013-12-25 Biouniversa S.r.l. BAG3 as biochemical serum and tissue marker
ITMI20131351A1 (it) 2013-08-07 2015-02-08 Biouniversa Srl Molecole leganti il recettore di bag3 per uso terapeutico.
ITUB20155097A1 (it) 2015-11-05 2017-05-05 Biouniversa Srl Anticorpi umanizzati anti-BAG3
IT201600069391A1 (it) * 2016-07-04 2016-10-04 Univ Degli Studi Di Salerno Uso della proteina bag3 e suoi frammenti peptidici per il controllo dell’omeostasi vascolare
IT201600111877A1 (it) 2016-11-07 2018-05-07 Biouniversa Srl Anti-BAG3 antibodies in combination with inhibitors of immune check-point for therapeutic use
JP6873460B2 (ja) * 2017-01-12 2021-05-19 テオリアサイエンス株式会社 被検者が膵臓癌に罹患している可能性を試験する方法
IT201700113648A1 (it) * 2017-10-10 2019-04-10 Biouniversa Srl Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases
US20210024623A1 (en) 2017-07-28 2021-01-28 Intrepida Bio, Inc. Anti-bag3 antibodies as therapeutic reagent in cardiovascular disease
WO2019178489A1 (en) * 2018-03-16 2019-09-19 Bristol-Myers Squibb Company Metabolic enzyme activity and disulfide bond reduction during protein production
WO2021140173A1 (en) 2020-01-10 2021-07-15 Biouniversa S.R.L. Methods and uses for treating fibrotic solid tumors with bags inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200618A2 (en) * 1999-07-09 2002-05-02 The Burnham Institute A method for determining the prognosis of cancer patients by measuring levels of bag expression
EP1323733A1 (en) * 2001-12-28 2003-07-02 Arturo Leone BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
JP2005229874A (ja) * 2004-02-18 2005-09-02 Institute Of Physical & Chemical Research Ｂａｇ３ドメインポリペプチド及びその用途
CA2650507A1 (en) * 2006-04-27 2007-11-08 Universite De Montreal Assessment and reduction of risk of graft-versus-host disease
CN101505791A (zh) * 2006-08-14 2009-08-12 株式会社未来创药研究所 使用抗桥粒芯蛋白3抗体的癌症的诊断和治疗
RU2537245C2 (ru) * 2006-10-12 2014-12-27 Чугаи Сейяку Кабусики Кайся Диагностика и лечение злокачественной опухоли с использованием антитела против ereg
CN101358976A (zh) * 2008-04-28 2009-02-04 北京华大吉比爱生物技术有限公司 检测六项肿瘤标志物的微阵列-酶联免疫检测试剂盒
IT1397083B1 (it) 2009-12-04 2012-12-28 Biouniversa Srl Marcatore biochimico serico

Also Published As

Publication number Publication date
KR20120121391A (ko) 2012-11-05
BR112012013418A2 (pt) 2017-12-12
CA2782544A1 (en) 2011-06-09
PT2507635E (pt) 2015-02-24
CA2782544C (en) 2019-08-06
KR101851392B1 (ko) 2018-04-23
JP5677450B2 (ja) 2015-02-25
EP2507635B1 (en) 2014-11-19
ITMI20092154A1 (it) 2011-06-05
CN102725638A (zh) 2012-10-10
BR112012013418B1 (pt) 2019-11-26
IT1397083B1 (it) 2012-12-28
JP2013513101A (ja) 2013-04-18
AU2010326600B2 (en) 2016-04-28
ES2530734T3 (es) 2015-03-05
WO2011067377A1 (en) 2011-06-09
CN102725638B (zh) 2014-08-20
DK2507635T3 (en) 2015-02-09
EP2507635A1 (en) 2012-10-10
US20120244561A1 (en) 2012-09-27
US8673585B2 (en) 2014-03-18
AU2010326600A1 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
HK1176678A1 (en) Biochemical serum marker
AP3379A (en) Assays
EP2523001A4 (en) REAGENT COMPOSITION FOR IMMUNOCHROMATOGRAPHY
GB0903469D0 (en) Assay
GB0914826D0 (en) Assay methods
GB0921447D0 (en) Assay
GB0918712D0 (en) An assay
GB0908589D0 (en) Assay method
AU326903S (en) Pipettes
AU326904S (en) Pipettes
GB0904639D0 (en) Assay
GB0902565D0 (en) Assay
GB0908071D0 (en) Marker
GB0811567D0 (en) Assay
GB0807534D0 (en) Assay
GB0803850D0 (en) Assay
GB0905964D0 (en) Marker
GB0811858D0 (en) Assay
GB0809262D0 (en) Assay
GB0921873D0 (en) Assay
GB0907516D0 (en) Assay
GB201114689D0 (en) Pipettes
GB0814591D0 (en) Assay
GB0913773D0 (en) Assay
GB0902493D0 (en) Assay method

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231203